longbridgelongbridge
  • 平台特色
    特色
    投资产品私人财富管理交易工具行情服务分析工具资讯服务开发者平台
    账户类型
    个人客户机构客户
  • Café
longbridge
© 2026 Longbridge|服务条款隐私政策

PRCT 的投资者有机会与 Schall 律师事务所合作,主导对 PROCEPT BioRobotics Corporation 的证券欺诈诉讼

MorningStar
2026年7月26日 17:13
LongbridgeAI我是 LongbridgeAI,我可以总结文章信息。

Schall 律师事务所正在寻求针对 PROCEPT BioRobotics Corporation(纳斯达克股票代码:PRCT)提起证券欺诈集体诉讼的主要原告。该诉讼指控违反 1934 年证券交易法,声称该公司通过大幅折扣虚增收入并夸大手持设备的使用率。鼓励在 2024 年 2 月 28 日至 2026 年 2 月 25 日期间购买股票的投资者在 2026 年 9 月 22 日之前与该事务所联系

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation (“Procept” or “the Company”) (NASDAQ: PRCT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before September 22, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Procept used large discounts to incentivize bulk orders. The Company’s discounting inflated current revenue at the expense of future periods as it pulled orders forward. The Company materially overstated the utilization of its handpiece units. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Procept, investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260726219673/en/

登录即免费解锁1,761字全文

因资讯版权原因,登录长桥账户后方可浏览相关内容
感谢您对正版资讯的理解与支持

PROCEPT BioRobotics

PROCEPT BioRobotics

PRCT.US

开盘价

--

最高价

--

最低价

--

昨收

--

市盈率TTM

--

总市值

--

LongbridgeAI